Lista de obras -

"Neurologist's contribution to the diagnosis of sine materia respiratory insufficiency: case report".

artículo científico publicado en 2012

A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia - Case Reports

artículo científico publicado en 2020

A budget impact analysis of bronchial thermoplasty for severe asthma in clinical practice

artículo científico publicado en 2014

Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case report

scientific article published on 01 September 2018

Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life

scientific article published on 29 December 2018

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights

artículo científico publicado en 2020

Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective

artículo científico publicado en 2018

Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?

artículo científico publicado en 2017

Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up.

artículo científico publicado en 2012

Clinical audit on diagnostic accuracy and management of respiratory failure in COPD.

artículo científico publicado en 2012

Clinical usefulness of mepolizumab in severe eosinophilic asthma

artículo científico publicado en 2016

Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?

artículo científico publicado en 2019

Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation

scientific article published on 01 July 2019

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation

artículo científico publicado en 2020

Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-85

artículo científico publicado en 2020

Evolving phenotypes to endotypes: is precision medicine achievable in asthma?

artículo científico publicado en 2020

Heat-induced necrosis after bronchial thermoplasty: a new concern?

artículo científico publicado en 2018

Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?

artículo científico publicado en 2017

Long-term benefits of omalizumab in a patient with severe non-allergic asthma

artículo científico publicado en 2011

May 2020: Is It Always COVID-19 No Matter What?

artículo científico publicado en 2020

Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential

artículo científico publicado en 2016

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty.

artículo científico publicado en 2017

Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma.

artículo científico publicado en 2018

Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review

artículo científico publicado en 2019

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

scientific article published on 20 September 2020

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?

artículo científico publicado en 2018

Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

artículo científico publicado en 2019

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

artículo científico publicado en 2015

Real-life Efficacy of Omalizumab After 9 Years of Follow-up.

artículo científico publicado en 2017

Recurrent lung atelectasis from fibrin plugs as a very early complication of bronchial thermoplasty: a case report

artículo científico publicado en 2015

Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?

artículo científico publicado en 2019

Severe refractory asthma: current treatment options and ongoing research

artículo científico publicado en 2018

Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma

scientific article published on 01 October 2018

Tailored therapy for severe asthma

artículo científico publicado en 2015

Targeting eosinophils: severe asthma and beyond

scientific article published on 23 July 2019

The Severe Asthma Network in Italy (SANI): findings and perspectives

article

The clinical profile of benralizumab in the management of severe eosinophilic asthma

artículo científico publicado en 2016

Towards precision medicine: The application of omics technologies in asthma management.

artículo científico publicado en 2018

Lista de obras de

"Neurologist's contribution to the diagnosis of sine materia respiratory insufficiency: case report".

A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia - Case Reports

A budget impact analysis of bronchial thermoplasty for severe asthma in clinical practice

Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case report

Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights

Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective

Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?

Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up.

Clinical audit on diagnostic accuracy and management of respiratory failure in COPD.

Clinical usefulness of mepolizumab in severe eosinophilic asthma

Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?

Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation

Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-85

Evolving phenotypes to endotypes: is precision medicine achievable in asthma?

Heat-induced necrosis after bronchial thermoplasty: a new concern?

Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?

Long-term benefits of omalizumab in a patient with severe non-allergic asthma

May 2020: Is It Always COVID-19 No Matter What?

Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty.

Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma.

Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?

Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

Real-life Efficacy of Omalizumab After 9 Years of Follow-up.

Recurrent lung atelectasis from fibrin plugs as a very early complication of bronchial thermoplasty: a case report

Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?

Severe refractory asthma: current treatment options and ongoing research

Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma

Tailored therapy for severe asthma

Targeting eosinophils: severe asthma and beyond

The Severe Asthma Network in Italy (SANI): findings and perspectives

The clinical profile of benralizumab in the management of severe eosinophilic asthma

Towards precision medicine: The application of omics technologies in asthma management.